Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Malaysian Approval of FLEXISEQ™ and Distribution Agreement

Abstract:
Pro Bono Bio™ is pleased to announce that its innovative product FLEXISEQ, a new nanotechnology based treatment for osteoarthritis, has received approval for sale in Malaysia. This follows the successful launch of FLEXISEQ in Europe earlier this year.

Malaysian Approval of FLEXISEQ™ and Distribution Agreement

Malaysia | Posted on June 18th, 2012

Pro Bono Bio is also pleased to announce that they have signed an agreement to distribute FLEXISEQ in Malaysia and the product will be available via local distribution company, Farmasia Sdn. Bhd. from early July 2012. Its first introduction to the local market is at the 42nd Annual Scientific Meeting of the Malaysian Orthopaedic Association in Kuantan, Malaysia held between the 14th and 17th of June 2012.

Michael Earl, COO of Pro Bono Bio, said "Pro Bono Bio is an ambitious new international pharmaceutical company which expects to make a real difference for patients, doctors and payors alike by developing truly innovative products to address areas of real need. It is a pleasure to launch our product FLEXISEQ here in Malaysia following our success in Europe. We look forward to introducing further innovative products this year and are also considering where to site our regional headquarters and manufacturing facilities to support our products in South East Asia."

Zohrah Razak Al Aidruss of Farmasia said "It is wonderful to have reached an agreement to introduce such an innovative product into Malaysia. The unique mode of action and lack of the side effects associated with various existing drug products, makes this a very welcome addition to the solutions available for physicians managing Osteoarthritis (OA). OA effects millions of patients in Malaysia, and both global and local trials have proved the effectiveness of FLEXISEQ at relieving joint pain associated with OA."

####

About Pro Bono Bio
Pro Bono Bio is a new international healthcare company based on the experience in pharmaceutical product development, commercialisation and finance of Celtic Pharma Holdings in the UK, international capital, along with investment and support from RUSNANO in Russia. Pro Bono Bio has ambitious growth targets that will allow it to support a unique humanitarian mission.

Pro Bono Bio launched its first medical device, FLEXISEQ, a new nanotechnology based pain treatment for osteoarthritis, in Europe in the first half of 2012. The Company also plans to launch two further new products for the treatment of inflammatory skin disorders in the second half of 2012. These new products are based on Pro Bono Bio's innovative Sequessome Technology™.

Pro Bono Bio is also developing new products to treat haemophilia as well as novel antibiotics for the treatment of serious infections such as C. difficile, MRSA, Pneumonia and Tuberculosis.

About FLEXISEQ

FLEXISEQ is the safe way to reduce joint pain associated with osteoarthritis. FLEXISEQ benefits from a Class 2A Medical Device certification in Europe. It is a topically applied gel which uses the unique Sequessome Technology to pass through the skin and apply a biolubricant layer inside the effected joint and along the cartilage. This improves the mobility in the joint and reduces the pain.

www.flexiseq.com

For more information, please click here

Contacts:
For further information please contact:
Zohrah Ab Razak Al-Aidruss


To order in Malaysia please contact:
Farmasia Sdn. Bhd.
+603-62032334

For London based press please contact:
Citigate Dewe Rogerson
David Dible / Nina Enegren
Tel: +44(0)207-282-1050

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers find new way to control light with electric fields May 25th, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

Nanomechanics, Inc. to Exhibit at the SEM Conference: Nanoindentation experts will attend and exhibit their instruments at the Conference and Exposition on Experimental and Applied Mechanics in Indianapolis May 25th, 2017

Three-dimensional graphene: Experiment at BESSY II shows that optical properties are tuneable May 24th, 2017

Govt.-Legislation/Regulation/Funding/Policy

Researchers find new way to control light with electric fields May 25th, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Graphene-nanotube hybrid boosts lithium metal batteries: Rice University prototypes store 3 times the energy of lithium-ion batteries May 19th, 2017

Stanford scientists use nanotechnology to boost the performance of key industrial catalyst May 18th, 2017

Nanomedicine

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Sensors detect disease markers in breath May 19th, 2017

Oddball enzyme provides easy path to synthetic biomaterials May 17th, 2017

The brighter side of twisted polymers: Conjugated polymers designed with a twist produce tiny, brightly fluorescent particles with broad applications May 16th, 2017

Announcements

Researchers find new way to control light with electric fields May 25th, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

Nanomechanics, Inc. to Exhibit at the SEM Conference: Nanoindentation experts will attend and exhibit their instruments at the Conference and Exposition on Experimental and Applied Mechanics in Indianapolis May 25th, 2017

Three-dimensional graphene: Experiment at BESSY II shows that optical properties are tuneable May 24th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project